← Open Payments lookup

WILLIAM GILLESPIE: Open Payments

NPI 1538238118 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,640 in 160 payments from 17 companies in 2025. Trend: 2023 $2,473 · 2024 $2,915 · 2025 $2,640

Food & beverage: $2,492Education: $148
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.20$437
Teva Pharmaceuticals USA, Inc.23$429
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$309
Janssen Pharmaceuticals, Inc15$247
Otsuka America Pharmaceutical, Inc.19$244
Neurocrine BioSciences, Inc.18$229
E.R. Squibb & Sons, L.L.C.13$192
Alkermes, Inc.17$166
Otsuka Pharmaceutical Development & Commercialization, Inc.1$144
Bausch Health US, LLC3$57

Products named: HETLIOZ, CAPLYTA, REXULTI, UZEDY, INGREZZA, COBENFY, ARISTADA, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.